Rex A Moats1, Kathryn D Moseley, Richard Koch, Marvin Nelson. 1. Department of Radiology, University of California/Keck School of Medicine at Childrens Hospital Los Angeles, Los Angeles, California 90027, USA. rmoats@chla.usc.edu
Abstract
OBJECTIVE: To assess the effects of 2 pharmacologic interventions (amino acid supplements) on the brain levels of phenylalanine (Phe) in adults with phenylketonuria (PKU). METHODS: A prospective study was conducted in an outpatient treatment and follow-up setting. The volunteers who were recruited for the first intervention included 4 subjects with classic PKU. The second intervention included 3 adults with classic PKU. The first intervention consisted of dietary supplementation during 1 day with Phlexy 10. Two individuals were given a dose of 0.5 g/kg/d, and 2 were given 1.0 g/kg/d. The second intervention consisted of dietary supplementation with PreKUnil at 0.4 g kg/d over a period of 6 months. Brain Phe was measured by magnetic resonance spectroscopy. The number of the patients involved precluded analysis for significance. RESULTS: The first, shorter intervention resulted in a decrease in brain Phe. The second intervention resulted in a 20% decrease in brain Phe, which was maintained after 6 months of treatment. CONCLUSION:Dietary supplementation of large neutral amino acids seems to lower the brain Phe in adults who have PKU and have difficulty following their diet.
RCT Entities:
OBJECTIVE: To assess the effects of 2 pharmacologic interventions (amino acid supplements) on the brain levels of phenylalanine (Phe) in adults with phenylketonuria (PKU). METHODS: A prospective study was conducted in an outpatient treatment and follow-up setting. The volunteers who were recruited for the first intervention included 4 subjects with classic PKU. The second intervention included 3 adults with classic PKU. The first intervention consisted of dietary supplementation during 1 day with Phlexy 10. Two individuals were given a dose of 0.5 g/kg/d, and 2 were given 1.0 g/kg/d. The second intervention consisted of dietary supplementation with PreKUnil at 0.4 g kg/d over a period of 6 months. Brain Phe was measured by magnetic resonance spectroscopy. The number of the patients involved precluded analysis for significance. RESULTS: The first, shorter intervention resulted in a decrease in brain Phe. The second intervention resulted in a 20% decrease in brain Phe, which was maintained after 6 months of treatment. CONCLUSION: Dietary supplementation of large neutral amino acids seems to lower the brain Phe in adults who have PKU and have difficulty following their diet.
Authors: D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff Journal: J Inherit Metab Dis Date: 2008-10-29 Impact factor: 4.982
Authors: A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen Journal: Orphanet J Rare Dis Date: 2017-10-12 Impact factor: 4.123
Authors: Danique van Vliet; Vibeke M Bruinenberg; Priscila N Mazzola; Martijn H J R van Faassen; Pim de Blaauw; Ido P Kema; M Rebecca Heiner-Fokkema; Rogier D van Anholt; Eddy A van der Zee; Francjan J van Spronsen Journal: PLoS One Date: 2015-12-01 Impact factor: 3.240
Authors: Danique van Vliet; Els van der Goot; Wiggert G van Ginkel; Martijn H J R van Faassen; Pim de Blaauw; Ido P Kema; Aurora Martinez; M Rebecca Heiner-Fokkema; Eddy A van der Zee; Francjan J van Spronsen Journal: Nutrients Date: 2019-09-19 Impact factor: 5.717